Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review (Q26851448)

main subject

anti-retroviral agent

0 references

1 reference

1 reference

N. Ford

1

1 reference

Z. Shubber

2

1 reference

A. Calmy

3

1 reference

C. Irvine

4

1 reference

C. Rapparini

5

1 reference

O. Ajose

6

1 reference

R. L. Beanland

7

1 reference

M. Vitoria

8

1 reference

M. Doherty

9

1 reference

K. H. Mayer

10

1 reference

language of work or name

1 reference

1 June 2015

1 reference

Clinical Infectious Diseases

published in

1 reference

volume

60 Suppl 3

1 reference

page(s)

S170-6

1 reference

Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Comparative efficacy of Lamivudine and emtricitabine: a systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

The statistical basis of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Transformations Related to the Angular and the Square Root

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Impact of telephonic psycho-social support on adherence to post-exposure prophylaxis (PEP) after rape

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Postexposure prophylaxis after sexual assaults: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Preventing human immunodeficiency virus infection among sexual assault survivors in Cape Town, South Africa: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Non-occupational post exposure prophylaxis as a biobehavioral HIV-prevention intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Piloting post-exposure prophylaxis in Kenya raises specific concerns for the management of childhood rape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Comparison of two HIV postexposure prophylaxis regimens among men who have sex with men in Amsterdam: adverse effects do not influence compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Selecting an antiretroviral regimen for human immunodeficiency virus postexposure prophylaxis in the occupational setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Non-occupational HIV post-exposure prophylaxis at a Sydney metropolitan sexual health clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Preexposure prophylaxis for HIV infection among African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Comprehensive care and HIV prophylaxis after sexual assault in rural South Africa: the Refentse intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

Occupational exposure to HIV: experience at a tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

inferred from DOI database lookup

7 January 2021

based on heuristic

Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092

inferred from DOI database lookup

7 January 2021

based on heuristic

Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV092